Role of Host Filamin Proteins in Regulating Filovirus Entry and Egress
宿主细丝蛋白在调节丝状病毒进入和排出中的作用
基本信息
- 批准号:10644499
- 负责人:
- 金额:$ 26.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-10 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:ActinsAffectAntibody TherapyAntiviral TherapyBAG3 geneBiochemicalBiological AssayCell FractionationCell SeparationCell divisionCell membraneCell physiologyCellsCellular MorphologyCessation of lifeComplexCytokinesisDevelopmentDisease OutbreaksEbolaEbola virusEyeFamilyFilopodiaFilovirusFutureGoalsHIV-1Host Defense MechanismHumanImmunologicsInfectionIntegrinsLaboratoriesLife Cycle StagesLinkLiquid substanceMagnetismMammalian CellMarburgvirusMediatingMembraneMicroscopyMolecularPathway interactionsProcessProteinsProteomeReagentRecombinantsRegulationRibonucleasesRoleSeminal fluidSiteSmall Interfering RNATestingTherapeutic InterventionTotal Internal Reflection FluorescentVesicleVesicular stomatitis Indiana virusViralViral Hemorrhagic FeversVirionVirusVirus AssemblyVirus DiseasesVirus ReplicationZoonosescell motilitychronic infectioncombatconfocal imagingcrosslinkdriving forceemerging pathogenextracellularfilamininsightlink proteinlong-term sequelaemembernonhuman primatenovelparticleprotein crosslinktraffickingubiquitin-protein ligasevirus host interaction
项目摘要
Filoviruses (Ebola [EBOV] and Marburg [MARV]) are zoonotic, emerging pathogens that cause sporadic and
global outbreaks of severe hemorrhagic fever in humans and non-human primates. As EBOV and MARV can
establish persistent infections in the CNS, semen, eye, and other immunologically privileged sites inaccessible
to antibody therapy, and their re-emergence can result in long-term sequelae and death, understanding of host
defense mechanisms that could lead to the development of new antiviral therapies is more critical than ever. Our
lab is at the forefront of identifying host proteins that interact both physically and functionally with the filovirus
VP40 matrix protein, the driving force for virus assembly and egress, to regulate these late stages of virus
replication. To better understand the functional filovirus-host interactome, our laboratory has focused on direct
interactions between the PPxY Late (L) domain motif conserved in the VP40 proteins of EBOV (eVP40) and
MARV (mVP40) and modular WW-domains from select host proteins. In addition to positive regulators of filovirus
egress, we have recently identified WW-domain interactors that negatively regulate VP40-mediated budding,
including YAP/TAZ, BAG3, and WWOX. While the impact of these negative regulators is likely multifactorial and
complex, we have made the intriguing observation that filamin B, a common downstream effector of YAP/TAZ
and BAG3, acts as a potential dual regulator of live EBOV/MARV infectivity/entry and live EBOV/MARV egress.
As dual role regulation of key stages at opposite ends of the filovirus lifecycle is novel and unexpected, the
ultimate goal of this proposal is to determine how host protein filamin B mechanistically impacts the filovirus
lifecycle. Filamins are a family of actin crosslinking/stabilizing proteins that regulate actin dynamics at the plasma
membrane to control cell migration and morphology, vesicle trafficking, macropinocytosis, and cell division.
Notably, macropinocytosis
macropinosomes
is
(MPs) that are densely coated with actin, filamin, and filamin-associated proteins
a key entry pathway for filoviruses, as these viruses enter the cell in vesicles
termed
. In addition,
filamins are linked to cellular processes that mimic virion formation and/or egress such as filopodia formation,
cell migration, and cytokinesis. Thus, we hypothesize that filamin B regulates infectivity/entry of filoviruses
through effects on macropinocytosis, and regulates filovirus budding through effects on egress of filopodia-like
filovirus particles. In this exploratory proposal, we propose to investigate the mechanisms by which filamin
regulates filovirus infectivity/entry (Aim 1) and egress (Aim 2). Results from these studies will impact the field by
identifying a novel host protein(s) whose expression modulates two critical and opposite steps in the filovirus
lifecycle; entry and exit, as well as providing a better fundamental understanding of the functional filovirus-host
interactome and host defense mechanisms that could lead to the development of new antiviral therapies.
丝病毒(埃博拉病毒[EBOV]和MARBUG [MARV])是人畜共患病,新兴的病原体会导致零星和
人类和非人类灵长类动物的严重出血热暴发。就像Ebov和Marv可以
在中枢神经系统,精液,眼睛和其他免疫学特权地点中建立持续感染
进行抗体疗法及其重新出现会导致长期后遗症和死亡,对宿主的理解
可能导致新抗病毒疗法发展的防御机制比以往任何时候都更为重要。我们的
实验室是识别与丝状病毒在物理和功能上相互作用的宿主蛋白的最前沿
VP40基质蛋白是病毒组装和出口的驱动力,用于调节病毒的晚期阶段
复制。为了更好地理解功能性的filevirus-Host Interactome,我们的实验室专注于直接
PPXY晚期(L)域基序之间的相互作用在EBOV的VP40蛋白(EVP40)和
MARV(MVP40)和来自选定宿主蛋白的模块化WW域。除了filevirus的积极调节剂
出口,我们最近确定了对VP40介导的萌芽的负调节的WW-domain相互作用者,
包括YAP/TAZ,BAG3和WWOX。尽管这些负调节器的影响可能是多因素的,并且
复杂的是,我们进行了一个有趣的观察,即Filamin B是YAP/TAZ的常见下游效应子
和Bag3,是实时EBOV/MARV感染/进入和Live Ebov/Marv Egress的潜在双调节器。
由于犯罪病毒生命周期相对端的关键阶段的双重角色调节是新颖且出乎意料的,因此
该提案的最终目标是确定宿主蛋白丝蛋白B如何机械影响丝状病毒
生命周期。 Filamins是肌动蛋白交联/稳定蛋白的家族,可调节血浆肌动蛋白动力学
控制细胞迁移和形态,囊泡运输,大型细胞增多症和细胞分裂的膜。
值得注意的是,大型细胞增多症
大刺体
是
(MPS)与肌动蛋白,丝蛋白和丝蛋白相关的蛋白密度密集
当这些病毒进入囊泡中时,丝状病毒的关键进入途径
称为
。此外,
丝蛋白与模仿病毒体形成和/或出口(例如丝状形成)的细胞过程有关,
细胞迁移和细胞因子。因此,我们假设Filamin B调节了丝状病毒的感染性/进入
通过对大型细胞增多症的影响,并通过对丝状病毒样的影响来调节丝状病毒。
丝状病毒颗粒。在此探索性建议中,我们建议研究丝胺的机制
调节丝状病毒感染/进入(AIM 1)和出口(AIM 2)。这些研究的结果将通过
识别一种新型宿主蛋白,该蛋白的表达调节了丝状病毒中的两个关键和相反的步骤
生命周期;进入和出口,并提供对功能性货币托管宿主的更好的基本了解
相互作用和宿主防御机制,可能导致新的抗病毒疗法的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD N HARTY其他文献
RONALD N HARTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD N HARTY', 18)}}的其他基金
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
针对严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 的面向宿主的疗法的开发,
- 批准号:
10688262 - 财政年份:2022
- 资助金额:
$ 26.83万 - 项目类别:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
针对严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 的面向宿主的疗法的开发,
- 批准号:
10545109 - 财政年份:2022
- 资助金额:
$ 26.83万 - 项目类别:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
宿主血管动蛋白作为丝状病毒排出和传播的中央调节剂的作用
- 批准号:
10380684 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
宿主血管动蛋白作为丝状病毒排出和传播的中央调节剂的作用
- 批准号:
10217843 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
Modular Domains of Host Proteins Regulate Filovirus Maturation
宿主蛋白的模块化结构域调节丝状病毒成熟
- 批准号:
9517218 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10257889 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10368115 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
针对出血热病毒的小分子疗法的开发
- 批准号:
10599837 - 财政年份:2018
- 资助金额:
$ 26.83万 - 项目类别:
DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSES
针对 RNA 病毒的小分子疗法的开发
- 批准号:
8903846 - 财政年份:2015
- 资助金额:
$ 26.83万 - 项目类别:
Innate Immune Regulation of Intracellular Pathways Involved in Filovirus Budding
丝状病毒出芽涉及的细胞内途径的先天免疫调节
- 批准号:
8635498 - 财政年份:2013
- 资助金额:
$ 26.83万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 26.83万 - 项目类别:
Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritis
创伤后骨关节炎中的纤维化、炎症和骨赘形成
- 批准号:
10570315 - 财政年份:2023
- 资助金额:
$ 26.83万 - 项目类别:
Regulation of Ku70 methylation and functions by SETD4
SETD4 对 Ku70 甲基化和功能的调节
- 批准号:
10546482 - 财政年份:2021
- 资助金额:
$ 26.83万 - 项目类别:
The role of macrophage podosomes in Ebola virus pathogenesis
巨噬细胞足体在埃博拉病毒发病机制中的作用
- 批准号:
10301361 - 财政年份:2020
- 资助金额:
$ 26.83万 - 项目类别:
The role of ARF6 in the progression of diabetic kidney disease
ARF6在糖尿病肾病进展中的作用
- 批准号:
10633151 - 财政年份:2019
- 资助金额:
$ 26.83万 - 项目类别: